English   español  
Please use this identifier to cite or link to this item: http://hdl.handle.net/10261/123726
Share/Impact:
Statistics
logo share SHARE logo core CORE   Add this article to your Mendeley library MendeleyBASE

Visualizar otros formatos: MARC | Dublin Core | RDF | ORE | MODS | METS | DIDL
Exportar a otros formatos:
Title

Using stem cells to produce insulin

AuthorsSoria Escoms, Bernat ; Gauthier, Benoit R.; Martín, Franz ; Bedoya Bergua, Francisco Javier ; Rojas, Anabel ; Hmadcha, Abdelkrim
Keywordsβ-cell
Cell differentiation
Diabetes
Islet development
Pancreatic organogenesis
Pluripotent stem cells
Issue Date9-Jul-2015
PublisherTaylor & Francis
CitationExpert Opinion on Biological Therapy 15(10): 1469-1489 (2015)
Abstract[Introduction]: Tremendous progress has been made in generating insulin-producing cells from pluripotent stem cells. The best outcome of the refined protocols became apparent in the first clinical trial announced by ViaCyte, based on the implantation of pancreatic progenitors that would further mature into functional insulin-producing cells inside the patients body. [Areas covered]: Several groups, including ours, have contributed to improve strategies to generate insulin-producing cells. Of note, the latest results have gained a substantial amount of interest as a method to create a potentially functional and limitless supply of β-cell to revert diabetes mellitus. This review analyzes the accomplishments that have taken place over the last few decades, summarizes the state-of-art methods for β-cell replacement therapies based on the differentiation of embryonic stem cells into glucose-responsive and insulin-producing cells in a dish and discusses alternative approaches to obtain new sources of insulin-producing cells. [Expert opinion]: Undoubtedly, recent events preface the beginning of a new era in diabetes therapy. However, in our opinion, a number of significant hurdles still stand in the way of clinical application. We believe that the combination of the private and public sectors will accelerate the process of obtaining the desired safe and functional β-cell surrogates.
Publisher version (URL)http://dx.doi.org/10.1517/14712598.2015.1066330
URIhttp://hdl.handle.net/10261/123726
DOI10.1517/14712598.2015.1066330
Identifiersdoi: 10.1517/14712598.2015.1066330
e-issn: 1744-7682
issn: 1471-2598
Appears in Collections:(CABIMER) Artículos
Files in This Item:
File Description SizeFormat 
Using stem cells.pdf962,32 kBAdobe PDFThumbnail
View/Open
Show full item record
Review this work
 

Related articles:


WARNING: Items in Digital.CSIC are protected by copyright, with all rights reserved, unless otherwise indicated.